Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

(2020) Victor M Corman et al.   Eurosurveillance

COVID-19 Associated Pulmonary Aspergillosis

(2020) Andreas L.E. van Arkel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

COVID-19, superinfections and antimicrobial development: What can we expect?

(2020) Cornelius J Clancy et al.   CLINICAL INFECTIOUS DISEASES

COVID‐19 associated pulmonary aspergillosis

(2020) Philipp Koehler et al.   MYCOSES

Burden of serious fungal infections in the Netherlands

(2020) Jochem B. Buil et al.   MYCOSES

CO-RADS – A categorical CT assessment scheme for patients with suspected COVID-19: definition and evaluation

(2020) Mathias Prokop et al.   RADIOLOGY

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

(2020) Alexandre Alanio et al.   Lancet Respiratory Medicine

High-Frequency Direct Detection of Triazole Resistance in Aspergillus fumigatus from Patients with Chronic Pulmonary Fungal Diseases in India

(2020) Ashutosh Singh et al.   Journal of Fungi

Diagnosing invasive pulmonary aspergillosis in ICU patients

(2019) Stijn Blot et al.   Current Opinion in Critical Care

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

(2019) J Peter Donnelly et al.   CLINICAL INFECTIOUS DISEASES

High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum

(2019) P. Vergidis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

(2018) A.J. Ullmann et al.   CLINICAL MICROBIOLOGY AND INFECTION

Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study

(2018) T. Boch et al.   JOURNAL OF CRITICAL CARE

Post-influenzal triazole-resistant aspergillosis following allogeneic stem cell transplantation

(2018) Alida Fe Talento et al.   MYCOSES

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

(2018) Alexander F A D Schauwvlieghe et al.   Lancet Respiratory Medicine

Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management

(2018) Pieter P.A. Lestrade et al.   CLINICAL MICROBIOLOGY AND INFECTION

Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus -specific Lateral Flow Device test in bronchoalveolar lavage

(2018) Jeffrey D. Jenks et al.   MYCOSES

A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit

(2017) Alida Fe Talento et al.   JOURNAL OF CRITICAL CARE

Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment

(2017) Anuradha Chowdhary et al.   JOURNAL OF INFECTIOUS DISEASES

Comparison of 1,3-β- d -glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients

(2016) Tobias Lahmer et al.   JOURNAL OF CRITICAL CARE

Clinical implications of globally emerging azole resistance inAspergillus fumigatus

(2016) Jacques F. Meis et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis

(2015) Gemma L. Johnson et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures

(2014) Suhail Ahmad et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Performance of Galactomannan, Beta-D-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis

(2014) M. Hoenigl et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Correction: Emergence of Azole-Resistant Aspergillus fumigatus Strains due to Agricultural Azole Use Creates an Increasing Threat to Human Health

(2013) Anuradha Chowdhary et al.   PLoS Pathogens

A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients

(2012) Stijn I. Blot et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease

(2011) J. Acosta et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Beta-d-Glucan Detection as a Diagnostic Test for Invasive Aspergillosis in Immunocompromised Critically Ill Patients with Symptoms of Respiratory Infection: an Autopsy-Based Study

(2011) Greet De Vlieger et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3) – β – d-glucan chromogenic assay in serum samples

(2010) J. Acosta et al.   CLINICAL MICROBIOLOGY AND INFECTION

Galactomannan in Bronchoalveolar Lavage Fluid

(2007) Wouter Meersseman et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE